Disclosure Of First-Time Adoption [Text Block]

BioPorto - Filing #1379628

Concept 2022-10-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-10-01 to
2022-12-31
2022-10-01 to
2022-12-31
2022-10-01 to
2022-12-31
2022-10-01 to
2022-12-31
2022-07-01 to
2022-09-30
As at
2022-09-30
As at
2022-09-30
As at
2022-09-30
As at
2022-09-30
As at
2022-09-30
2022-07-01 to
2022-09-30
2022-07-01 to
2022-09-30
2022-07-01 to
2022-09-30
2022-07-01 to
2022-09-30
As at
2022-06-30
As at
2022-06-30
As at
2022-06-30
2022-04-01 to
2022-06-30
As at
2022-06-30
As at
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
2022-04-01 to
2022-06-30
As at
2022-03-31
2022-01-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
2022-01-01 to
2022-03-31
2022-01-01 to
2022-03-31
As at
2022-03-31
2022-01-01 to
2022-03-31
2022-01-01 to
2022-03-31
As at
2022-03-31
2021-10-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-10-01 to
2021-12-31
2021-10-01 to
2021-12-31
2021-10-01 to
2021-12-31
2021-10-01 to
2021-12-31
As at
2021-09-30
2021-07-01 to
2021-09-30
As at
2021-09-30
As at
2021-09-30
As at
2021-09-30
As at
2021-09-30
2021-07-01 to
2021-09-30
2021-07-01 to
2021-09-30
2021-07-01 to
2021-09-30
2021-07-01 to
2021-09-30
As at
2021-06-30
As at
2021-06-30
As at
2021-06-30
2021-04-01 to
2021-06-30
As at
2021-06-30
As at
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
2021-04-01 to
2021-06-30
As at
2021-03-31
2021-01-01 to
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
As at
2021-03-31
2021-01-01 to
2021-03-31
2021-01-01 to
2021-03-31
2021-01-01 to
2021-03-31
2021-01-01 to
2021-03-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
Disclosure of first-time adoption [text block]
Disclosure of comparative information prepared under previous GAAP [text block]
Disclosure of comparative information prepared under previous GAAP [abstract]
Disclosure of comparative information prepared under previous GAAP [line items]
Equity
70,221,000 DKK
234,000 DKK
264,238,000 DKK
- DKK
334,693,000 DKK
91,080,000 DKK
2,299,000 DKK
- DKK
241,314,000 DKK
334,693,000 DKK
107,917,000 DKK
- DKK
878,000 DKK
334,693,000 DKK
225,898,000 DKK
- DKK
169,000 DKK
123,907,000 DKK
334,693,000 DKK
210,617,000 DKK
- DKK
119,000 DKK
267,754,000 DKK
221,671,000 DKK
45,964,000 DKK
62,821,000 DKK
267,754,000 DKK
- DKK
363,000 DKK
205,296,000 DKK
76,474,000 DKK
267,754,000 DKK
192,177,000 DKK
- DKK
897,000 DKK
86,738,000 DKK
871,000 DKK
- DKK
180,715,000 DKK
266,582,000 DKK
1,100,000 DKK
- DKK
100,912,000 DKK
166,770,000 DKK
266,582,000 DKK
Comprehensive income
2,065,000 DKK
76,038,000 DKK
2,065,000 DKK
- DKK
- DKK
- DKK
1,421,000 DKK
- DKK
1,421,000 DKK
- DKK
- DKK
709,000 DKK
- DKK
709,000 DKK
- DKK
- DKK
50,000 DKK
- DKK
- DKK
50,000 DKK
- DKK
- DKK
58,332,000 DKK
- DKK
- DKK
482,000 DKK
482,000 DKK
534,000 DKK
- DKK
- DKK
- DKK
534,000 DKK
26,000 DKK
- DKK
- DKK
- DKK
26,000 DKK
229,000 DKK
- DKK
- DKK
- DKK
229,000 DKK
Profit (loss)
24,925,000 DKK
75,923,000 DKK
- DKK
- DKK
- DKK
24,925,000 DKK
16,877,000 DKK
16,877,000 DKK
- DKK
- DKK
- DKK
17,091,000 DKK
17,091,000 DKK
- DKK
- DKK
- DKK
17,030,000 DKK
- DKK
17,030,000 DKK
- DKK
- DKK
16,742,000 DKK
57,113,000 DKK
- DKK
- DKK
- DKK
16,742,000 DKK
11,384,000 DKK
11,384,000 DKK
- DKK
- DKK
- DKK
13,623,000 DKK
- DKK
- DKK
13,623,000 DKK
- DKK
15,364,000 DKK
15,364,000 DKK
- DKK
- DKK
- DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.